Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 12 (1) , 81-87
- https://doi.org/10.1023/a:1008384019411
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Construction and validation of a practical prognostic index for patients with metastatic breast cancer.Journal of Clinical Oncology, 1998
- Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.Journal of Clinical Oncology, 1997
- Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow supportCancer, 1994
- Survival after first recurrence of breast cancer. The miami experienceCancer, 1992
- Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1991
- Influence of age on the metastatic behavior of breast carcinomaHuman Pathology, 1988
- Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.Journal of Clinical Oncology, 1988
- Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.Journal of Clinical Oncology, 1987
- Survival after first recurrence in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Multivariate analysis of prognostic factors in metastatic breast cancer.Journal of Clinical Oncology, 1983